Dr. Caroline Y. Chang, MD Pediatrics - Pediatric Rheumatology Medicare: Medicare Enrolled Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 |
Dr. David Easa, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou Street, Honolulu, HI 96826 Phone: 808-983-6242 Fax: 808-983-6240 |
Brachelle Nueku, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou St Fl 7, Honolulu, HI 96826 Phone: 808-369-1200 |
Dr. Yolanda C. Wu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-6641 Fax: 808-983-6937 |
Dr. Joan Ceccarelli Meister, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-8670 Fax: 808-983-6392 |
Dr. Megan Danielle Blair, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou Street, #741, Honolulu, HI 96826 Phone: 808-369-1200 Fax: 808-369-1212 |
Barbora Kadecka, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou Street #741, Pediatric Residency Program, Honolulu, HI 96826 Phone: 781-296-7641 |
Dr. Tonya Marie Kratovil, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-294-3961 |
Dr. Michael L Walter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 915 N King St, Honolulu, HI 96817 Phone: 808-848-1438 Fax: 808-843-7270 |
Jasmine K Waipa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 615 Piikoi St Ste 1501, Honolulu, HI 96814 Phone: 808-600-2180 |
James Charles Demarco, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1177 Queen St, #4403, Honolulu, HI 96814 Phone: 808-589-2906 |
Dr. Keith Ken Abe, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St Ste 999, Honolulu, HI 96826 Phone: 808-947-1402 |
Dr. Wallace J Matthews Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 S King St, Suite 300, Honolulu, HI 96814 Phone: 808-593-9944 Fax: 808-593-0565 |
Dr. Kristin Kawailoa Fernandez, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-6000 Fax: 808-983-6109 |
Chunmei Wu, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou St, #910, Honolulu, HI 96826 Phone: 808-949-3534 Fax: 808-380-8419 |
Michael Murayama, Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 |
Rachel Coel, MD Pediatrics - Sports Medicine Medicare: Medicare Enrolled Practice Location: 550 S Beretania St, Physician Office Bldg 3, Suite 703, Honolulu, HI 96813 Phone: 808-691-4449 Fax: 808-691-4015 |
Kenneth D. Dougan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 |
Dr. Vince Ken Yamashiroya, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1010 S King St, Suite 105, Honolulu, HI 96814 Phone: 808-596-2030 Fax: 808-596-2034 |
Dr. Melinda Ashton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1319 Punahou St, Suite 1100, Honolulu, HI 96826 Phone: 808-955-7845 Fax: 808-946-3071 |
News Archive
The Norwegian researchers have taken part in an international cooperative effort to map 110 genetic variations that increase the risk of MS and MG. Most of these genetic variations have been mapped in recent years.
New research has found that people who consume relatively high amounts of flavonols have a lower risk of stroke. Tea was most likely the major contributor of flavonols in the diet, ranging from 30 percent (US) to 70 percent (the Netherlands) of the total intake.
Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers. However, the risk may not be as high as previously thought.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Twenty-five percent of inflammatory bowel disease (IBD) patients are diagnosed as children or adolescents - at the peak of their social and educational development.
› Verified 6 days ago